AR and prostate carcinoma: The pathophysiology of prostate cancer underscores the significance of androgen receptor (AR) activation and AR-driven transcriptional programs, making androgen deprivation therapy (ADT) and androgen-receptor targeted therapy (ART) essential treatments1.